2023
Health service delivery factors influencing neonatal mortality in health facilities in the bono region of Ghana
Brobbey R, Kwawukume M, Twum P, Agyei-Baffour P, Opoku D, Antwi-Berko N, Vetsi O, Apara J, Mensah K. Health service delivery factors influencing neonatal mortality in health facilities in the bono region of Ghana. World Journal Of Advanced Research And Reviews 2023, 17: 157-176. DOI: 10.30574/wjarr.2023.17.3.0368.Peer-Reviewed Original Research
2018
Granulomatosis With Polyangiitis in a Young Adult With Down Syndrome
Mensah KA, Pascha V, Moeckel G, Danve A. Granulomatosis With Polyangiitis in a Young Adult With Down Syndrome. JCR Journal Of Clinical Rheumatology 2018, 24: 153-156. PMID: 29200025, DOI: 10.1097/rhu.0000000000000633.Peer-Reviewed Original ResearchAcute Kidney InjuryAdultAntibodies, Antineutrophil CytoplasmicBiopsyBlood TransfusionDiagnosis, DifferentialDown SyndromeGlucocorticoidsGranulomatosis with PolyangiitisHemoptysisHumansImmunoglobulins, IntravenousImmunologic FactorsKidneyMalePatient Care ManagementPatient SelectionRespiration, ArtificialRespiratory InsufficiencyRituximabTomography, X-Ray ComputedTreatment Outcome
2017
Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review
Bazan IS, Mensah KA, Rudkovskaia AA, Adonteng-Boateng PK, Herzog EL, Buckley L, Fares WH. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review. Respiratory Medicine 2017, 134: 42-46. PMID: 29413506, DOI: 10.1016/j.rmed.2017.11.020.BooksConceptsPulmonary arterial hypertensionConnective tissue disease-associated pulmonary arterial hypertensionConnective tissue diseasePulmonary hypertensionSSc-PAHArterial hypertensionSystemic sclerosisTissue diseaseElevated left ventricular filling pressurePathobiology of PAHLeft ventricular filling pressureMixed connective tissue diseasePre-capillary pulmonary hypertensionWorld Health Organization classificationSetting of lupusSetting of sclerodermaPulmonary vascular resistanceRight heart failureVentricular filling pressurePAH etiologyPathophysiologic criteriaSLE-PAHVascular resistanceProgressive diseaseSystemic lupusCyanosis of the foot.
Shi VJ, Leventhal JS, Mensah KA, Galan A, Choate KA. Cyanosis of the foot. Cutis 2017, 100: 206;209;210. PMID: 29136053.Peer-Reviewed Original Research
2015
Lupus‐Associated Pulmonary Arterial Hypertension: Variable Course and Importance of Prompt Recognition
Mensah KA, Yadav R, Trow TK, Brunet CM, Fares WH. Lupus‐Associated Pulmonary Arterial Hypertension: Variable Course and Importance of Prompt Recognition. Case Reports In Medicine 2015, 2015: 328435. PMID: 26229536, PMCID: PMC4503546, DOI: 10.1155/2015/328435.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsPulmonary arterial hypertensionSystemic lupus erythematosusVariable courseRight-sided heart pressuresSevere pulmonary arterial hypertensionLife-threatening symptomsLong-term outcomesEvidence-based therapiesEffective treatment approachArterial hypertensionMultiorgan dysfunctionSLE flareHeart pressuresLupus erythematosusPrompt recognitionCirculatory shockSame patientTreatment approachesYoung womenLevel interventionsSymptomsSignificant improvementReportErythematosusHypertension
2014
Chapter 2. Diagnosis and Imaging of Insufficiency Fractures
Mensah KA and Schneider R. Insufficiency Fractures. Eds. Lane JM and Saleh A. Rosemont, IL: American Academy of Orthopaedic Surgeons, 2014.Peer-Reviewed Original Research
2013
Chapter 6. Basic Science of Immunology in Orthopaedics
Mensah KA and O’Keefe RJ. Orthopaedic Basic Science: Foundations of Clinical Practice, Fourth Edition. Eds. O'Keefe RJ, Jacobs JJ, Chu CR, and Einhorn TA. Rosemont, IL: American Academy of Orthopaedic Surgeons, 2013.Peer-Reviewed Original ResearchAtypical Femoral Fractures
Unnanuntana A, Saleh A, Mensah KA, Kleimeyer JP, Lane JM. Atypical Femoral Fractures. Journal Of Bone And Joint Surgery 2013, 95: e8. PMID: 23324969, DOI: 10.2106/jbjs.l.00568.Peer-Reviewed Original Research
2011
Regulation of human osteoclast development by dendritic cell‐specific transmembrane protein (DC‐STAMP)
Chiu Y, Mensah KA, Schwarz EM, Ju Y, Takahata M, Feng C, McMahon LA, Hicks DG, Panepento B, Keng PC, Ritchlin CT. Regulation of human osteoclast development by dendritic cell‐specific transmembrane protein (DC‐STAMP). Journal Of Bone And Mineral Research 2011, 27: 79-92. PMID: 21987375, PMCID: PMC3304467, DOI: 10.1002/jbmr.531.Peer-Reviewed Original ResearchConceptsDendritic cell-specific transmembrane proteinImmunoreceptor tyrosine-based inhibitory motifOC precursorsInflammatory arthritisTransmembrane proteinSH2 domain-containing tyrosine phosphataseTransmembrane receptor-like proteinErosive inflammatory arthritisCell fusionTumor giant cellsMetabolic bone diseaseReceptor-like proteinDC-STAMP expressionTyrosine-based inhibitory motifCell surface receptorsBone diseaseHuman PBMCsTyrosine phosphataseOsteoclast developmentCytoplasmic tailGiant cellsCellular transformationOC formationOsteoclastogenesisSHP-1
2010
Mediation of nonerosive arthritis in a mouse model of lupus by interferon‐α–stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis
Mensah KA, Mathian A, Ma L, Xing L, Ritchlin CT, Schwarz EM. Mediation of nonerosive arthritis in a mouse model of lupus by interferon‐α–stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis. Arthritis & Rheumatism 2010, 62: 1127-1137. PMID: 20131244, PMCID: PMC2854832, DOI: 10.1002/art.27312.Peer-Reviewed Original ResearchConceptsMyeloid dendritic cellsSystemic lupus erythematosusSerum-induced arthritisNZB xBone erosionDendritic cellsOsteoclast precursorsAntibody titersMouse modelAnti-dsDNA antibody titersDNA antibody titersMicrofocal computed tomographyCytokine interferon-alphaEffects of IFNalphaJaccoud's arthritisNonerosive arthritisSLE diseaseJoint inflammationLupus erythematosusAutoimmune diseasesNZW miceSerum administrationInterferon alphaFocal erosionsSLE monocytesCD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis
Chiu YG, Shao T, Feng C, Mensah KA, Thullen M, Schwarz EM, Ritchlin CT. CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Research & Therapy 2010, 12: r14. PMID: 20102624, PMCID: PMC2875642, DOI: 10.1186/ar2915.Peer-Reviewed Original ResearchConceptsCD16 expressionOC precursorsInflammatory arthritisHealthy controlsMethodsPeripheral blood mononuclear cellsNuclear factor kappa-B ligandCD16-positive monocytesSubset of CD14Chronic inflammatory arthritisBlood mononuclear cellsHuman peripheral bloodCD16 surface expressionColony-stimulating factorPsA patientsPsoriatic arthritisBone erosionDendritic cellsPsoriasis subjectsMononuclear cellsPeripheral bloodTumor necrosisCD16Receptor activatorBone wafersArthritis
2009
RANKL induces heterogeneous DC‐STAMPlo and DC‐STAMPhi osteoclast precursors of which the DC‐STAMPlo precursors are the master fusogens
Mensah KA, Ritchlin CT, Schwarz EM. RANKL induces heterogeneous DC‐STAMPlo and DC‐STAMPhi osteoclast precursors of which the DC‐STAMPlo precursors are the master fusogens. Journal Of Cellular Physiology 2009, 223: 76-83. PMID: 20039274, PMCID: PMC2814997, DOI: 10.1002/jcp.22012.Peer-Reviewed Original ResearchMeSH KeywordsAcid PhosphataseAnimalsAntigens, CDBiomarkersBlotting, WesternBone Marrow CellsCD47 AntigenCell DifferentiationCell FusionCells, CulturedFlow CytometryImmunoproliferative DisordersIsoenzymesMacrophagesMembrane GlycoproteinsMembrane ProteinsMiceMice, Inbred C57BLMicroscopy, FluorescenceNerve Tissue ProteinsOsteoclastsPhenotypeProtein MultimerizationRANK LigandReverse Transcriptase Polymerase Chain ReactionRNA, MessengerStem CellsTartrate-Resistant Acid PhosphataseTetraspanin 29Time FactorsThe emerging field of osteoimmunology
Mensah KA, Li J, Schwarz EM. The emerging field of osteoimmunology. Immunologic Research 2009, 45: 100-113. PMID: 19184540, PMCID: PMC2934875, DOI: 10.1007/s12026-009-8093-x.Peer-Reviewed Original ResearchConceptsRheumatoid arthritisAdaptive immune effector cellsImmune effector cellsTreatment of autoimmuneField of osteoimmunologyMetabolic bone diseaseSkeletal systemImmune cell ontogenySubsequent effector functionsBasic science findingsEffector cellsAutoimmune diseasesInflammatory diseasesBone diseaseEffector functionsBone microenvironmentBiologic drugsDiseaseCell ontogenyBone biologyClinical applicationEffector moleculesOsteoimmunologyRecent findingsRecent studies
2008
Altered bone remodeling in psoriatic arthritis
Mensah KA, Schwarz EM, Ritchlin CT. Altered bone remodeling in psoriatic arthritis. Current Rheumatology Reports 2008, 10: 311-317. PMID: 18662512, PMCID: PMC2656567, DOI: 10.1007/s11926-008-0050-5.Peer-Reviewed Original ResearchConceptsPsoriatic arthritisTumor necrosis factor inhibitionInflammatory joint diseaseNecrosis factor inhibitionBasic science findingsInflammatory arthritisNew bone formationBone resorptionFactor inhibitionJoint diseaseBone homeostasisArthritisBone formationAltered boneSkeletal systemBone biologyDynamic organClinical applicationPivotal roleRecent studiesBoneOsteoimmunologyScience findings